knowledge -WSS

knowledge

author：focus 2025-09-06 02:15:04 - browse：1

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Diversify hospital leadership teams to protect BIPOC patient health

WSS

Readout Newsletter: The latest on Novavax, Merck, Bluebird

White House calls on federal agencies to crack down on AI abuses

Abortion clinic in Cancun will cater to Americans

Will General Catalyst be the first of many hospital takeovers?

Syphilis numbers in the United States reach record heights

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

focus

knowledge

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

Extreme heat events are a public health emergency

Walensky prepares to leave CDC — and Congress — behind

Investment in vaccine development is lagging, report finds

Dobbs anniversary: the lost opportunity of abortion as health care

Philips to halt sales of sleep apnea machines in U.S.

Medicare proposal to cover medical devices draws a mixed reaction

How generative AI ratchets up security threats for health systems

Peter Hotez and the public health issue of online harassment

Humana’s losses in Medicare Advantage tank its stock

Wikipedia

MoonLake credibility takes another hit with mid

Medicare will require more price transparency from hospitals

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

10 million people disenrolled from Medicaid over past six months

The new shift in health care is toward less care

entertainment

entertainment

Wikipedia

explore